Abbott reported $4.68B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Agilent USD 608M 7M Jun/2026
AtriCure USD 80.24M 1.5M Sep/2026
Baxter International USD 1.02B 10M Sep/2026
Becton, Dickinson and Co. USD 6.11B 173M Jun/2026
Bio-Rad Laboratories USD 133.5M 10M Sep/2026
Boston Scientific USD 1.25B 19M Sep/2026
Cooper Companies USD 251.2M 17.9M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Dexcom USD 2.08B 134.8M Jun/2026
Edwards Lifesciences USD 199.7M 10.8M Sep/2026
Globus Medical USD 107.43M 487K Sep/2026
Insulet USD 162.2M 38.9M Sep/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
Intuitive Surgical USD 2.56B 645M Sep/2026
J&J USD 9.32B 94M Sep/2026
Medtronic USD 2.7B 51M Jun/2026
Merit Medical Systems USD 70.74M 2.88M Jun/2026
Pfizer USD 4.07B 511M Sep/2026
Smith & Nephew USD 1.62B 426M Jun/2026
Solventum Corp USD 808M 107M Sep/2026
Stryker USD 1.66B 71M Jun/2026
Tandem Diabetes Care USD 74.8M 10.67M Sep/2026
Teleflex USD 142.87M 423K Sep/2026
Terumo JPY 76.76B 3.03B Sep/2026
Thermo Fisher Scientific USD 3.09B 181M Sep/2026
Zimmer Biomet Holdings USD 357.5M 5.1M Sep/2026